Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab

By sjmartinez • May 13, 2025

Kim GH, Zhang X, Brown MS, Poole L, Goldin J. Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab. BMJ Open. 2025 May 12;15(5):e094559. doi: 10.1136/bmjopen-2024-094559. PMID: 40355288.

Tags: Chest imaging, Computed tomography, interstitial lung disease, Patient reported outcome measures, Publications, Pulmonary Disease, Pulmonary, Critical Care & Sleep Medicine, QUALITATIVE RESEARCH

Actionable Clinical Features and Biomarkers to Facilitate the Management of Irritable Bowel Syndrome

Shin A, Staller K, Levinthal DJ. Actionable Clinical Features and Biomarkers to Facilitate the Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2025 Nov 19.[...]

First imported cases of MPXV Clade Ib from Goma, Democratic Republic of the Congo

Mukadi-Bamuleka D, Kinganda-Lusamaki E, Mulopo-Mukanya N, Amuri-Aziza A, O'Toole Á, Merritt S, Modadra-Madakpa B, Mutombo-Ndongala G, Vakaniaki EH, Kacita C, Maboko GL, Makangara-Cigolo JC, Ngimba[...]

Quantifying the impact of early life growth adversity on later life health

Goldman-Pham R, Alter MP, Bao R, Collins SÉ, Debban CL, Allinson JP, Ambler A, Bertoni AG, Caspi A, Lovinsky-Desir S, Ekstrom MP, Engert JC, Jacobs[...]